QUIC on the Highway: Evaluating Performance on High-rate Links

QUIC is a new protocol standardized in 2021 designed to improve on the widely used TCP / TLS stack. The main goal is to speed up web traffic via HTTP, but it is also used in other areas like tunneling. Based on UDP it offers features like reliable in-order delivery, flow and congestion control, streambased multiplexing, and always-on encryption using TLS 1.3. Other than with TCP, QUIC implements all these features in user space, only requiring kernel interaction for UDP. While running in user space provides more flexibility, it profits less from efficiency and optimization within the kernel. Multiple implementations exist, differing in programming language, architecture, and design choices. This paper presents an extension to the QUIC Interop Runner, a framework for testing interoperability of QUIC implementations. Our contribution enables reproducible QUIC benchmarks on dedicated hardware. We provide baseline results on 10G links, including multiple implementations, evaluate how OS features like buffer sizes and NIC offloading impact QUIC performance, and show which data rates can be achieved with QUIC compared to TCP. Our results show that QUIC performance varies widely between client and server implementations from 90 Mbit/s to 4900 Mbit/s. We show that the OS generally sets the default buffer size too small, which should be increased by at least an order of magnitude based on our findings. Furthermore, QUIC benefits less from NIC offloading and AES NI hardware acceleration while both features improve the goodput of TCP to around 8000 Mbit/s. Our framework can be applied to evaluate the effects of future improvements to the protocol or the OS.Comment: Presented at the 2023 IFIP Networking Conference (IFIP Networking

Exchange of ejecta between Telesto and Calypso: Tadpoles, horseshoes, and passing orbits

We have numerically integrated the orbits of ejecta from Telesto and Calypso, the two small Trojan companions of Saturn's major satellite Tethys. Ejecta were launched with speeds comparable to or exceeding their parent's escape velocity, consistent with impacts into regolith surfaces. We find that the fates of ejecta fall into several distinct categories, depending on both the speed and direction of launch. The slowest ejecta follow sub-orbital trajectories and re-impact their source moon in less than one day. Slightly faster debris barely escape their parent's Hill sphere and are confined to tadpole orbits, librating about Tethys' triangular Lagrange points L4 (leading, near Telesto) or L5 (trailing, near Calypso) with nearly the same orbital semi-major axis as Tethys, Telesto, and Calypso. These ejecta too eventually re-impact their source moon, but with a median lifetime of a few dozen years. Those which re-impact within the first ten years or so have lifetimes near integer multiples of 348.6 days (half the tadpole period). Still faster debris with azimuthal velocity components >~ 10 m/s enter horseshoe orbits which enclose both L4 and L5 as well as L3, but which avoid Tethys and its Hill sphere. These ejecta impact either Telesto or Calypso at comparable rates, with median lifetimes of several thousand years. However, they cannot reach Tethys itself; only the fastest ejecta, with azimuthal velocities >~ 40 m/s, achieve "passing orbits" which are able to encounter Tethys. Tethys accretes most of these ejecta within several years, but some 1 % of them are scattered either inward to hit Enceladus or outward to strike Dione, over timescales on the order of a few hundred years

The Role of Ejecta in the Small Crater Populations on the Mid-Sized Saturnian Satellites

We find evidence that crater ejecta play an important role in the small crater populations on the Saturnian satellites, and more broadly, on cratered surfaces throughout the Solar System. We measure crater populations in Cassini images of Enceladus, Rhea, and Mimas, focusing on image data with scales less than 500 m/pixel. We use recent updates to crater scaling laws and their constants to estimate the amount of mass ejected in three different velocity ranges: (i) greater than escape velocity, (ii) less than escape velocity and faster than the minimum velocity required to make a secondary crater (v_min), and (iii) velocities less than v_min. Although the vast majority of mass on each satellite is ejected at speeds less than v_min, our calculations demonstrate that the differences in mass available in the other two categories should lead to observable differences in the small crater populations; the predictions are borne out by the measurements we have made to date. Rhea, Tethys, and Dione have sufficient surface gravities to retain ejecta moving fast enough to make secondary crater populations. The smaller satellites, such as Enceladus but especially Mimas, are expected to have little or no traditional secondary populations because their escape velocities are near the threshold velocity necessary to make a secondary crater. Our work clarifies why the Galilean satellites have extensive secondary crater populations relative to the Saturnian satellites. The presence, extent, and sizes of sesquinary craters (craters formed by ejecta that escape into temporary orbits around Saturn before re-impacting the surface) is not yet well understood. Finally, our work provides further evidence for a "shallow" size-frequency distribution (slope index of ~2 for a differential power-law) for comets a few km diameter and smaller. [slightly abbreviated]Comment: Submitted to Icarus. 77 double-spaced pages, including 25 figures and 5 table

Dilute suspensions in annular shear flow under gravity: simulation and experiment

A dilute suspension in annular shear flow under gravity was simulated using multi-particle collision dynamics (MPC) and compared to experimental data. The focus of the analysis is the local particle velocity and density distribution under the influence of the rotational and gravitational forces. The results are further supported by a deterministic approximation of a single-particle trajectory and OpenFOAM CFD estimations of the overcritical frequency range. Good qualitative agreement is observed for single-particle trajectories between the statistical mean of MPC simulations and the deterministic approximation. Wall contact and detachment however occur earlier in the MPC simulation, which can be explained by the inherent thermal noise of the method. The multi-particle system is investigated at the point of highest particle accumulation that is found at 2/3 of the particle revolution, starting from the top of the annular gap. The combination of shear flow and a slowly rotating volumetric force leads to strong local accumulation in this section that increases the particle volume fraction from overall 0.7% to 4.7% at the outer boundary. MPC simulations and experimental observations agree well in terms of particle distribution and a close to linear velocity profile in radial direction

Clinical outcomes of radiation therapy for transgender and gender-expansive people with cancer

IntroductionApproximately 1.6 million people in the US identify as transgender, many of whom undergo gender-affirming medical or surgical therapies. While transgender individuals are diagnosed with cancer at similar rates as those who are cisgender, the impacts of radiation therapy on outcomes of gender-affirming care in transgender, nonbinary, and gender-expansive people with cancer are understudied. We report on the experiences and outcomes of transgender and gender-expansive patients receiving radiation therapy for cancer treatment.MethodsThis study is a multi-institutional retrospective review of patients evaluated from 2005-2019 identified as transgender or gender-expansive in the medical record and treated with radiation therapy.ResultsWe identified 23 patients who received radiation to 32 sites, including 12 (38%) to the brain, head, or neck, 8 (25%) to the thorax, and 7 (22%) to the pelvis. Seventeen patients (74%) received gender-affirming hormone therapy and 13 patients (57%) underwent gender-affirming surgery. Four patients had pelvic radiation before or after gender-affirming pelvic surgery, including two trans women who had pelvic radiation after vaginoplasty. Four patients had radiation to the chest or thorax and gender-affirming chest or breast surgery, including two trans men with breast cancer. Two pediatric patients developed hypopituitarism and hypogonadism secondary to radiation therapy and, as adults, changed their hormone replacement therapy to affirm their transgender identities.DiscussionTransgender people with cancer undergo radiation therapy for a wide range of cancers. Understanding their prior gender-affirming medical or surgical treatments and future gender affirmation goals may identify important considerations for their oncologic care

The effect of web advertising visual design on online purchase intention: An examination across gender

With web advertising growing to be a huge industry, it is important to understand the effectiveness of web advertisement. In this study we investigate the effects of web advertising visual design (WAVD) purchasing intention within the framework of an integrated model. Nine hypotheses were developed and tested on a dataset of 316 observations collected via a questionnaire survey. The results of structural equation modeling (SEM) indicate that while web advertising visual cues influence consumers' purchasing intention through advertising attitudes and brand attitudes, they do not have direct effects on purchasing intention. Further results on the moderating role of gender suggest that web advertising visual cues have direct effect on consumers' purchasing intention for male groups but not for female groups. This study contributes to the understanding the role of visual dimensions in forming online purchase intentions

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis

New therapeutic strategies are needed to combat the tuberculosis pandemic and the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) forms of the disease, which remain a serious public health challenge worldwide1, 2. The most urgent clinical need is to discover potent agents capable of reducing the duration of MDR and XDR tuberculosis therapy with a success rate comparable to that of current therapies for drug-susceptible tuberculosis. The last decade has seen the discovery of new agent classes for the management of tuberculosis3, 4, 5, several of which are currently in clinical trials6, 7, 8. However, given the high attrition rate of drug candidates during clinical development and the emergence of drug resistance, the discovery of additional clinical candidates is clearly needed. Here, we report on a promising class of imidazopyridine amide (IPA) compounds that block Mycobacterium tuberculosis growth by targeting the respiratory cytochrome bc1 complex. The optimized IPA compound Q203 inhibited the growth of MDR and XDR M. tuberculosis clinical isolates in culture broth medium in the low nanomolar range and was efficacious in a mouse model of tuberculosis at a dose less than 1 mg per kg body weight, which highlights the potency of this compound. In addition, Q203 displays pharmacokinetic and safety profiles compatible with once-daily dosing. Together, our data indicate that Q203 is a promising new clinical candidate for the treatment of tuberculosis

Panel 6 : Vaccines

Objective. To review the literature on progress regarding (1) effectiveness of vaccines for prevention of otitis media (OM) and (2) development of vaccine antigens for OM bacterial and viral pathogens. Data Sources. PubMed database of the National Library of Science. Review Methods. We performed literature searches in PubMed for OM pathogens and candidate vaccine antigens, and we restricted the searches to articles in English that were published between July 2011 and June 2015. Panel members reviewed literature in their area of expertise. Conclusions. Pneumococcal conjugate vaccines (PCVs) are somewhat effective for the prevention of pneumococcal OM, recurrent OM, OM visits, and tympanostomy tube insertions. Widespread use of PCVs has been associated with shifts in pneumococcal serotypes and bacterial pathogens associated with OM, diminishing PCV effectiveness against AOM. The 10-valent pneumococcal vaccine containing Haemophilus influenzae protein D (PHiD-CV) is effective for pneumococcal OM, but results from studies describing the potential impact on OM due to H influenzae have been inconsistent. Progress in vaccine development for H influenzae, Moraxella catarrhalis, and OM-associated respiratory viruses has been limited. Additional research is needed to extend vaccine protection to additional pneumococcal serotypes and other otopathogens. There are likely to be licensure challenges for protein-based vaccines, and data on correlates of protection for OM vaccine antigens are urgently needed. Implications for Practice. OM continues to be a significant health care burden globally. Prevention is preferable to treatment, and vaccine development remains an important goal. As a polymicrobial disease, OM poses significant but not insurmountable challenges for vaccine development.Peer reviewe